Elevance Health, Inc. ELV
Set alert
As of Nov 2, 10:54 AM ET
- YTD
- +17.30%
- 1 year
- +29.63%
- Open
- 421.34
- Prev close
- 420.07
- Mkt cap
- 89.06B
- Vol
- 294.43K
- Avg vol
- 1.16M
- EPS
- 23.55
- P/E
- 17.44
- Div yield
- 1.63%
More statistics
- Low
- 408.84
- High
- 424.11
- Forward P/E
- 13.84
- Beta
- 0.71
- Short ratio
- 4.04
- Inst. own
- 94.38%
- Dividend
- 6.88
- Ex-div date
- Dec 3, 2026
- Earnings
- Jan 27, 2027
- 50-d avg
- 410.09
- 200-d avg
- 372.12
- 1y target
- 482.38
5D chart
Events in this range
- Oct 27, 2026Rating: Wells Fargo · Overweight → Overweight
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 10:40 AM | 14 minutes ago |
| SMA: Bullish | Nov 2, 10:20 AM | 34 minutes ago |
| RSI: Oversold | Nov 2, 9:40 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 hour ago |
| SMA: Bullish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:00 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:55 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:40 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:25 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:35 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:10 PM | 4 days ago |
| RSI: Oversold | Oct 28, 1:40 PM | 4 days ago |
| RSI: Oversold | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 10:50 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:35 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:05 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:45 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:35 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:30 AM | 6 days ago |
| SMA: Bullish | Oct 27, 11:25 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:45 AM | 6 days ago |
News
2 days ago zacks.com
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should Know
Does Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.
-
6 days ago benzinga.com
Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.
6 days ago gurufocus.com
ELV Fairly Valued by DCF at $418
On October 27, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown notable price performance over the past year, with a
6 days ago defenseworld.net
Elevance Health, Inc. $ELV Stock Acquired by Citizens Financial Group Inc. RI
Citizens Financial Group Inc. RI increased its position in shares of Elevance Health, Inc. (NYSE: ELV) by 77.0% in the undefined quarter, according to the company in its most recent 13F filing with…
1 week ago zacks.com
Implied Volatility Surging for Elevance Health Stock Options
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
1 week ago defenseworld.net
Elevance Health, Inc. $ELV Stock Sold by Iridian Asset Management LLC CT
Iridian Asset Management LLC CT decreased its holdings in Elevance Health, Inc. (NYSE: ELV) by 31.6% in the third quarter, according to its most recent Form 13F filing with the Securities and…
1 week ago defenseworld.net
Elevance Health (NYSE:ELV) Stock: Insider Mark Kaye Sells 10,584 Shares
Elevance Health, Inc. (NYSE: ELV - Get Free Report) CFO Mark Kaye sold 10,584 shares of the stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of…
1 week ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 week ago zacks.com
ELV vs. RVTY: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Revvity (RVTY). But which of these two stocks offers value investors a better bang…
-
1 week ago benzinga.com
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.
-
1 week ago benzinga.com
UBS Maintains Buy on Elevance Health, Raises Price Target to $523
UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $523.
-
1 week ago benzinga.com
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $485
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $485.
-
1 week ago benzinga.com
Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.
-
1 week ago benzinga.com
RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $424 to $455.
-
1 week ago benzinga.com
Barclays Maintains Overweight on Elevance Health, Raises Price Target to $472
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $469 to $472.
-
1 week ago benzinga.com
Baird Maintains Neutral on Elevance Health, Raises Price Target to $406
Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $393 to $406.
1 week ago seekingalpha.com
Elevance Health: Better Results, But Not Enough To Buy
Elevance Health raised its 2026 adjusted EPS guidance to at least $29, but the sustainability of its earnings recovery remains uncertain. Third-quarter adjusted EPS rose 15.9%, while nine-month…
1 week ago fool.com
Elevance: 3 Key Takeaways for Long-Term Investors
Elevance raised its 2026 earnings baseline to at least $26.75 per share. Carelon's cancer program reduced avoidable inpatient admissions by 15%.
1 week ago zacks.com
2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG
Intuitive Surgical (ISRG) and Elevance Health (ELV) delivered impressive Q3 earnings beats, making both healthcare stocks worth considering as their growth outlooks improve.
1 week ago zacks.com
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?
Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
1 week ago seekingalpha.com
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
1 week ago zacks.com
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
Elevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.
1 week ago marketbeat.com
What Elevance Health (ELV) Said on Its Q3 Earnings Call
Elevance Health NYSE: ELV raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company's expectations as Medicaid, Medicare…
1 week ago benzinga.com
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
1 week ago zacks.com
Compared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key…
1 week ago benzinga.com
Elevance Health Q3 2026 Earnings Call Transcript
Elevance Health (NYSE:ELV) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
1 week ago zacks.com
Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates
Elevance Health (ELV) came out with quarterly earnings of $6.99 per share, beating the Zacks Consensus Estimate of $4.66 per share. This compares to earnings of $6.03 per share a year ago.
1 week ago businesswire.com
Elevance Health Names Jeff Park President of Carelon
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the appointment of Jeff Park as President of Carelon, effective December 1, 2026. In this role, Park will lead Carelon…
1 week ago wsj.com
Elevance Health Raises Yearly Outlook as Profit, Revenue Rise
For the third quarter, the health-insurance company reported a rise in net income to $1.34 billion, or $6.27 a share, compared with $1.19 billion, or $5.32 a share, a year earlier.
1 week ago reuters.com
Elevance lifts 2026 profit forecast on better medical cost management
Elevance lifts 2026 profit forecast on better medical cost management
-
1 week ago benzinga.com
Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate
Elevance Health (NYSE:ELV) reported quarterly earnings of $6.99 per share which beat the analyst consensus estimate of $4.68 by 49.36 percent. This is a 15.92 percent increase over earnings of $6.03…
1 week ago businesswire.com
Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across…
-
3 weeks ago benzinga.com
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $460
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $455 to $460.
-
3 weeks ago benzinga.com
Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders
Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on Elevance Health, Raises Price Target to $469
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $457 to $469.
1 month ago benzinga.com
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
1 month ago benzinga.com
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.
2 months ago benzinga.com
Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today
The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
2 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago benzinga.com
Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2
Value investor Seth Klarman reveals his latest stock picks in a second quarter filing for hedge fund Baupost Group.
2 months ago benzinga.com
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs
Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
2 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago benzinga.com
Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’
Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.
3 months ago benzinga.com
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
3 months ago benzinga.com
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It
Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1…
3 months ago benzinga.com
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.
3 months ago benzinga.com
Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.
3 months ago benzinga.com
Earnings Scheduled For July 15, 2026
Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly…
3 months ago benzinga.com
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit
Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.
4 months ago benzinga.com
UNH, Humana, CVS Soar, and Wall Street Analysts Take Note
Top healthcare insurance stocks like UNH, CVS, and Humana stocks are rising after the Medicare advantage payment hike and analysts are taking note.